IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Q4 2017 Holdings

Filed 2018-02-09 | 16 holdings | $11.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Anika Therapeutics Inc(ANIK)COM035255108$6.2M114,60052.3%
Charles RIV Labs Intl Inc(CRL)COM159864107$2.9M26,71224.8%
Biogen Inc(BIIB)COM09062X103$2.7M8,40022.7%
Laboratory Corp Amer HldgsCOM NEW50540R409$2.8K17,8000.0%
Quest Diagnostics Inc(DGX)COM74834L100$2.8K28,5000.0%
Cardinal Health Inc(CAH)COM14149Y108$2.8K45,6000.0%
Mckesson Corp(MCK)COM58155Q103$2.8K17,8000.0%
Anthem Inc(ELV)COM036752103$2.8K12,3000.0%
Ligand Pharmaceuticals Inc(LGND)COM NEW53220K504$2.8K20,2000.0%
Medtronic PLC(MDT)SHSG5960L103$2.8K34,2000.0%
Cigna CorporationCOM125509109$2.7K13,4000.0%
Pfizer Inc(PFE)COM717081103$2.7K75,1000.0%
Waters Corp(WAT)COM941848103$2.7K14,0000.0%
Lilly ELI & Co(LLY)COM532457108$2.7K32,0000.0%
Bristol Myers Squibb Co(BMY)COM110122108$2.7K43,4000.0%
Gilead Sciences Inc(GILD)COM375558103$2.6K36,1000.0%